InspireMD (NSPR) News Today → Democrats Push to Replace Dollar With Digital Coin, Control Currency. (From Monetary Gold) (Ad) Free NSPR Stock Alerts $2.30 -0.08 (-3.36%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 1:37 PM | marketbeat.comInspireMD (NYSE:NSPR) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPSInspireMD (NYSE:NSPR - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.06). The company had revenue of $1.51 million during the quarter, compared to the consensus estimate of $1.38 million. InspireMD had a negative net margin of 320.97% and a negative return on equity of 55.71%. During the same period in the prior year, the company posted ($0.53) EPS.May 15 at 3:44 AM | markets.businessinsider.comInspireMD earnings preview: what Wall Street is expectingMay 14 at 12:20 PM | investorplace.comNSPR Stock Earnings: InspireMD Misses EPS, Beats Revenue for Q1 2024May 14 at 7:00 AM | globenewswire.comInspireMD Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 12, 2024 | americanbankingnews.comInspireMD (NSPR) to Release Quarterly Earnings on TuesdayMay 10, 2024 | americanbankingnews.comInspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.comMay 7, 2024 | globenewswire.comInspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14thApril 26, 2024 | ca.finance.yahoo.comInspireMD, Inc. (NSPR)April 8, 2024 | marketbeat.comInspireMD (NYSE:NSPR) Receives New Coverage from Analysts at StockNews.comStockNews.com started coverage on InspireMD in a report on Monday. They set a "sell" rating on the stock.April 3, 2024 | finance.yahoo.comInspireMD to Present at the 23rd Annual Needham Virtual Healthcare ConferenceApril 3, 2024 | globenewswire.comInspireMD to Present at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 31, 2024 | msn.comPope Francis appeals for Gaza cease-fire and Russia-Ukraine prisoner swap in Easter Sunday prayersMarch 26, 2024 | globenewswire.comInspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024March 7, 2024 | marketbeat.comInspireMD (NYSE:NSPR) Releases Earnings Results, Beats Expectations By $0.04 EPSInspireMD (NYSE:NSPR - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.04. InspireMD had a negative net margin of 353.86% and a negative return on equity of 64.05%. During the same quarter last year, the firm earned ($0.60) EPS.March 6, 2024 | finanznachrichten.deInspireMD, Inc.: InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateMarch 6, 2024 | investorplace.comNSPR Stock Earnings: InspireMD Beats EPS, Beats Revenue for Q4 2023March 6, 2024 | globenewswire.comInspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateMarch 5, 2024 | benzinga.comPreview: InspireMD's EarningsFebruary 28, 2024 | globenewswire.comInspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6thFebruary 21, 2024 | ca.finance.yahoo.comNSPR Mar 2024 7.500 callFebruary 4, 2024 | marketbeat.comStockNews.com Initiates Coverage on InspireMD (NYSE:NSPR)StockNews.com initiated coverage on InspireMD in a report on Sunday. They set a "sell" rating for the company.February 1, 2024 | msn.comInspireMD Announces CE Mark Recertification Under MDRFebruary 1, 2024 | msn.comInspireMD Secures CE Mark Recertification Under New EU StandardsJanuary 23, 2024 | finance.yahoo.comWe're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash WiselyNovember 27, 2023 | msn.comInspireMD (NSPR) Price Target Increased by 11.49% to 4.95November 23, 2023 | msn.comDown -24.61% in 4 Weeks, Here's Why InspireMD, Inc. (NSPR) Looks Ripe for a TurnaroundNovember 6, 2023 | markets.businessinsider.comInspireMD earnings: here's what Wall Street expectsNovember 6, 2023 | msn.comInspireMD GAAP EPS of -$0.15 misses by $0.01, revenue of $1.56M beats by $0.06MNovember 6, 2023 | finance.yahoo.comInspireMD Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 3, 2023 | msn.comInspireMD Q3 2023 Earnings PreviewNovember 1, 2023 | markets.businessinsider.comInspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial at VIVA23September 25, 2023 | markets.businessinsider.comPiper Sandler Remains a Buy on InspireMD (NSPR)September 22, 2023 | finance.yahoo.comInspireMD's CGuard(TM) Carotid Embolic Prevention System Featured in Live Case at Cracow Vascular Summit 2017 in PolandAugust 31, 2023 | msn.comInspireMD (NSPR) Price Target Increased by 5.45% to 4.44August 16, 2023 | finance.yahoo.comHere's Why We're Not Too Worried About InspireMD's (NASDAQ:NSPR) Cash Burn SituationAugust 3, 2023 | msn.comInspireMD (NSPR) Price Target Increased by 6.45% to 4.21July 6, 2023 | msn.comInspireMD (NSPR) Price Target Decreased by 18.42% to 3.95June 26, 2023 | finanznachrichten.deInspireMD, Inc.: InspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical TrialJune 26, 2023 | finance.yahoo.comInspireMD Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption (IDE) Clinical TrialJune 17, 2023 | ca.finance.yahoo.comNSPR - InspireMD, Inc.June 14, 2023 | msn.comPiper Sandler Initiates Coverage of InspireMD (NSPR) with Overweight RecommendationNovember 28, 2022 | benzinga.comInspireMD Announces "12 Days of Carotid Stenting" Video Series Featuring Fireside Chats with Top Multidisciplinary Vascular SpecialistsNovember 11, 2022 | uk.finance.yahoo.comInspireMD Third Quarter 2022 Earnings: Beats ExpectationsNovember 8, 2022 | seekingalpha.comInspireMD, Inc. (NSPR) Q3 2022 Earnings Call TranscriptNovember 8, 2022 | finanznachrichten.deInspireMD, Inc.: InspireMD Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 8, 2022 | technews.tmcnet.comInspireMD Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 8, 2022 | msn.comEarnings Scheduled For November 8, 2022September 15, 2022 | morningstar.comInspireMD Announces Presentation at the 2022 Transcatheter Cardiovascular Therapeutics (TCT) Conference | MorningstarSeptember 8, 2022 | finance.yahoo.comNAMSA and InspireMD Announce Strategic Outsourcing Partnership to Accelerate New Product DevelopmentAugust 2, 2022 | finance.yahoo.comInspireMD to Report Second Quarter 2022 Financial Results on August 9, 2022, and Provide Corporate Business Update Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Tiny AI projects with huge promise hiding in plain sight … (Ad)I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars. Click here to find out who they are. NSPR Media Mentions By Week NSPR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NSPR News Sentiment▼-0.760.55▲Average Medical News Sentiment NSPR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NSPR Articles This Week▼70▲NSPR Articles Average Week Get InspireMD News Delivered to You Automatically Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: APYX News Today CTSO News Today DRIO News Today LUCD News Today XAIR News Today AMIX News Today ICCM News Today GBS News Today HSAQ News Today CTCX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NSPR) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InspireMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
